Market Place
Sourcing Support
All News #Library
Biotech
Ensoma Clears U.K. Trial For EN-374, Gene Therapy
10 Dec 2025 //
BUSINESSWIRE
Profluent Bio, Ensoma Partner To Develop AI Base Editors
09 Dec 2025 //
BUSINESSWIRE
Ensoma Initiates Phase 1/2 Trial For EN-374 In X-CGD
01 Dec 2025 //
BUSINESSWIRE
Fierce Biotech Layoff Tracker 2025: Ensoma, Applied Tx & More
21 Nov 2025 //
FIERCE BIOTECH
Genetic Medicines Biotech Halves Team
20 Nov 2025 //
FIERCE BIOTECH
Ensoma Shows In Vivo HSC-Derived CAR-M/NK/T Platform Data
04 Nov 2025 //
BUSINESSWIRE
Ensoma To Present Preclinical Data At SITC 2025
03 Oct 2025 //
BUSINESSWIRE
Ensoma Raises $53M for EN-374, In Vivo Stem Cell Pipeline
22 Sep 2025 //
BUSINESSWIRE
Ensoma`s FDA Clears IND for First In Vivo HSC Gene Therapy
12 May 2025 //
BUSINESSWIRE
Ensoma to Present Data & Advancements at ASGCT Meeting
29 Apr 2025 //
BUSINESSWIRE
Ensoma Unveils Programs in Genetic, Immune & Oncological Diseases
05 Nov 2024 //
BUSINESSWIRE
Ensoma Appoints Jon Garen Chief Corp Dev and Business Officer
28 Oct 2024 //
BUSINESSWIRE
Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio
05 Jan 2023 //
BIOSPACE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.